Flowcarbon's versatile team merges investment banking, project finance, tax credit and other financial markets expertise to streamline access to creative capital solutions for the world’s most innovative companies in the infrastructure, decarbonization, and other niche sectors. Flowcarbon is headquartered in New York, United States and was founded in 2021.
GeNeuro is a biotechnology company that develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of the human endogenous retroviral origin. The company is primarily focused on nervous system diseases such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody for the treatment of multiple sclerosis. It also develops diagnostic tests to dose the multiple sclerosis-associated retrovirus-ENV proteins in patients.GeNeuro was founded in 2006 and is based in Plan-Les-Ouates, Switzerland.
Copper Banking was founded with the mission to help teens gain real world experience by giving them access to their money in a way that traditional banks aren’t able to do. The Copper app and debit card teaches teens how to make smart financial decisions by creating a platform for parents and teens to connect. With the Copper app, you get easy snapshots of your accounts and, with the Copper Debit Card, it's easy to shop in-store, online or with Apple or Google Pay. PLUS, users get exclusive access to engaging content curated by a team of financial literacy experts who provide advice and tips on how to take control of their financial future.
Swiggy is an on-demand food delivery platform that brings food from neighborhood restaurants directly to customers' doors. The company's food delivery platform lists local restaurants and menu lists on an app for users to order from and track the delivery of its delivery executives, enabling users to order food with speed and convenience. Its service is used to pick up and drop off a diverse array of items, including laundry and document or parcel deliveries to business clients and retail customers.
Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.
Pine Labs offers a merchant platform that includes technology and financial solutions for merchants. These solutions are aimed at helping merchants in increasing their revenue and reduce cost, complexity, and risk. The company connects financial institutions and consumer brands to enable merchants to deliver value to their retail customers. It powers offline and online last-mile retail transactions, provides customer insights for targeted sales, and offers financial solutions. The company’s cloud-based platform powers 3,50,000+ POS terminals across 3700 cities and towns in India and Malaysia. Over 1,00,000 merchants across sectors - electronics, food and beverage, fashion, airlines, and more, use Pine Labs’ solutions. 15 major banks, 7 financial institutions, and 100+ brands are part of Pine Labs’ platform.
Aumni is an investment analytics platform for private capital markets that include venture funds, family offices, university endowments, and corporate venture firms. By combining the best of A.I. and human expertise, Aumni’s platform extracts and analyzes critical deal data buried in dense legal agreements. Aumni has analyzed an unprecedented breadth and depth of private capital data representing investors with over $1 trillion in assets under management. The company was founded by former BigLaw corporate attorneys, Tony Lewis and Kelsey Chase in Salt Lake City, Utah.
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Raymond Management is a full service property management company focused on helping investment property owners maximize the return on, and value of their real estate assets.
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Godrej Properties brings the Godrej Group philosophy of innovation and excellence to the real estate industry. Each Godrej Properties development combines a 119-year legacy of excellence and trust with a commitment to cutting-edge design and technology. Godrej Properties is currently developing residential, commercial and township projects spread across 10.3 million square meters (111 million square feet) in 12 cities.
Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.
Expert.ai is a developer of enterprise natural language processing (NLP) technologies. Expert.ai is the developer of the software Cogito Discover, which taps AI to perform analytics, extraction, and categorization across taxonomies, making text from XML, RDF, and other formats available for automation and more. Expert.ai also offers Clinical Research Navigator, which supports biomedical clients with a platform designed to drive research into therapies for infectious diseases like COVID-19.
Clarksons offers its diverse and growing client base an unrivalled range of shipbroking services, sector research, on-hand logistical support and full investment banking capabilities in all key shipping and offshore sectors.
Dynamic, adaptable, and scalable, intelliflo redblack's intuitive software makes the complex simple, helping your business achieve growth and build value. Our intelliflo redblack software powers rebalancing and trading for registered investment advisors (RIAs) of all sizes including family offices. Firms that use our software offer greater value to their clients - at scale. A single solution delivers comprehensive rebalancing and trading capabilities with portfolio monitoring, pre-trade and post-trade compliance, and order management. Our industry-leading capabilities enable advisors to achieve superior precision, enhanced personalization and valuable efficiencies. intelliflo redblack integrates seamlessly with any technology stack.
Grab operates a mobile technology platform that integrates city transportation for driver-partners and customers in South East Asia. It offers services like GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. Grab offers services in Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Anthony Tan and Tan Hooi Lng founded it in 2012 and is headquartered in Singapore. It has additional offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam.
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
They are dedicated to serving the needs of our clients, who range from financial advisors and individual investors to corporations and endowments.
intelliflo widens access to financial advice through leading technology which powers the financial advisory experience. We use open software architectures combined with unmatched industry experience to simplify a complex digital landscape to help our customers thrive and grow. Bringing together five leading businesses in the financial services sector, intelliflo now provides a broader range of solutions than ever before, covering: financial planning, practice management, portfolio management, digital advisory and managed services. Our solutions support over 30,000 financial professionals worldwide, representing over three million end-investors, with over $900 billion advised across our platforms. intelliflo’s systems are designed for firms of all shapes and sizes, and though the technology we’ve developed is sophisticated, using it couldn’t be simpler. In a rapidly evolving industry, we are constantly developing our platforms to better serve the changing needs of our customers and their clients. Mission: We widen access to financial advice.
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
T She Dingzhi offers a platform for clothes design. Their business enables additional, fully-customizable t-shirts, hoodies, and sweaters to its clients. Through responsible, managed services, subscription cultural apparel, and other means, they are dedicated to assisting businesses in improving their services. It adapts and pursues accuracy and exquisite, repeatedly setting the bar for the sector.
Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Source is uniquely positioned to deliver highly liquid products that respond to the challenges and opportunities of the market They partner with some of the world’s largest investment houses and asset managers to create products that either offer exposure to new opportunities in the market or deliver existing strategies more effectively. They work together to ensure all of their products are efficient and transparent. On top of this, they work closely with some of the most well respected trading houses in Europe to ensure that their products are also priced as fairly as possible and are tradable throughout the day. Source is a global investment firm and one of the fastest growing European providers of exchange traded products (ETPs) By focusing on the ever-evolving needs of investors, they have grown assets under management to more than $19 billion (as at 30 July 2014) since their launch in April 2009, and during this time investors have traded more than $575 billion of Source’s products. They offer investors an efficient and transparent way to invest in equities, fixed income and commodities, as well as some alternative asset classes. Their ETPs are open-ended and domiciled in Dublin.
Glide Pharmaceutical Technologies is a clinical stage development company that focuses on solid dose formulations of therapeutics and vaccines. The company develops SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. Glide Pharmaceutical Technologies was formerly known as Caretek Medical.
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.
Private Equity Round in 2016
Nexeon is a leading international developer and manufacturer of breakthrough silicon-based anode materials for rechargeable lithium-ion batteries. These are fundamental to the achievement of ‘net zero’ and a sustainable environment. Nexeon’s battery materials enable significantly higher cell energy density, allowing the design of lighter, smaller and more cost effective batteries. In turn, this leads to enhanced performance for an increasing range of diverse consumer and commercial markets, including electric vehicles, where range and charging times can beneficially be impacted. Nexeon is based in Oxfordshire with operations in Japan. It has a well-established multi-disciplinary technical team with a wide range of expertise. For more details, please visit https://www.nexeon.co.uk
Jemstep is transforming the way investment advisors run their businesses through an automated client engagement, onboarding and service platform. With Jemstep Advisor Pro, advisors can attract more prospects, increase AUM, and service clients more efficiently. Jemstep award-winning advisor platform provides powerful client engagement and onboarding capabilities while integrating on the back-end with best of breed service providers such as Veo, Salesforce, Orion, Fiserv and others to provide RIAs, BD's and advisors with a complete and customizable business system that augments their value proposition.
Private Equity Round in 2015
Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. <a href="http://www.gelesis.com/">Gelesis</a> was founded in 2006 in Boston, Massachusetts
Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Private Equity Round in 2015
Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especially beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.
Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient's immune system to recognize, attack, and clear their cancer.
SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.
Luminex Trading & Analytics is a creator of an equity trading platform designed to provide access to clean, natural block liquidity at significantly lower trading costs. They're interacting only with venue-approved participants, the platform provides low-cost trading with minimal information leakage, allowing traders to execute large block trades with less market impact.
Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs manufactures and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9. Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.
Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
Private Equity Round in 2014
Generator Hostel provides owns and operates hostels that provide accommodations (shared to private) for travelers.
Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.
Ensurge develops ultrathin, flexible, and safe energy storage solutions for wearable devices, connected sensors, and beyond. Ensurge's innovative solid-state lithium battery (SSLB) technology is uniquely positioned to enable the production of powerful, lightweight, and cost-effective rechargeable batteries for diverse applications. The company's state-of-the-art flexible electronics manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of SSLB technology to established and expanding markets. Ensurge Micropower is a publicly listed company in Norway with corporate headquarters in Oslo and global headquarters in San Jose, California.
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
infirst HEALTHCARE is a new consumer healthcare company focused on improving well established drugs with IP protected solutions for the OTC/Primary care markets which can be launched within 12-36 months. infirst is a spin-out from SEEK, a UK privately-owned drug discovery group which uses its intellectual property to create breakthrough medicines addressing major diseases, bringing radical improvements to human health. infirst is led by CEO, Manfred Scheske, who was previously President of GSK's US$3 billion European Consumer Healthcare business (including brands such as alli, Aquafresh, Beechams, Corsodyl, Lucozade, Niquitin, Panadol. Piriton, Poligrip, Ribena, Sensodyne, Solpadeine, Zantac and Zovirax) from 2004 to 2010 and also spent six years as President of GSK's Consumer Healthcare business in North America
Xeros Ltd. is a new company focused on the development of "virtually waterless" laundry cleaning. Harnessing over 30 years of research by Professor Stephen Burkinshaw and the University of Leeds, Xeros is the brand name for a patented polymer based cleaning that creates step change advantage in the cost and environmental impact of aqueous wash cleaning.
Glide Pharmaceutical Technologies is a clinical stage development company that focuses on solid dose formulations of therapeutics and vaccines. The company develops SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. Glide Pharmaceutical Technologies was formerly known as Caretek Medical.
Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient's immune system to recognize, attack, and clear their cancer.
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science, and environmental research. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance, and education. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.
Spin Memory, Inc. specializes in developing spin-transfer torque magnetoresistive random access memory (STT-MRAM) technologies and products. Founded in 2007 and based in Fremont, California, the company focuses on addressing the scaling and power challenges faced by memory devices. Its solutions are designed to replace on-chip SRAM and various non-volatile memories in both embedded and stand-alone applications. Spin Memory's proprietary orthogonal spin transfer MRAM technology, discovered by Professor Andrew Kent, offers significant advantages, including faster switching times, reduced power consumption, and improved scalability. The company aims to provide clients with cost-effective MRAM solutions that eliminate leakage power and overcome endurance and data retention limitations inherent in traditional memory technologies.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
Nexeon is a leading international developer and manufacturer of breakthrough silicon-based anode materials for rechargeable lithium-ion batteries. These are fundamental to the achievement of ‘net zero’ and a sustainable environment. Nexeon’s battery materials enable significantly higher cell energy density, allowing the design of lighter, smaller and more cost effective batteries. In turn, this leads to enhanced performance for an increasing range of diverse consumer and commercial markets, including electric vehicles, where range and charging times can beneficially be impacted. Nexeon is based in Oxfordshire with operations in Japan. It has a well-established multi-disciplinary technical team with a wide range of expertise. For more details, please visit https://www.nexeon.co.uk
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science, and environmental research. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance, and education. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
MaxWest Environmental Systems develops a system with a gasification and heat integration process that converts biosolids into energy.
Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient's immune system to recognize, attack, and clear their cancer.
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science, and environmental research. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance, and education. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
LogLogic is the provider of industry's only scalable log and security intelligence platform for the enterprise and cloud. LogLogic, with over 1300 customers, provides solutions that allow customers to collect and analyze terabytes of big data generated by their IT assets and gives Security, IT Ops, and Compliance professionals actionable information at their finger tips to identify issues proactively and make insightful decisions, and also get compliant with various regulations. Currently, LogLogic customers are leveraging its solutions to manage over 1,000 Petabytes (or 1 Exabyte) of data.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
At NovaSys Health they value your participation as a contracted provider. Roughly 11,000 providers in this region and over 4,300 providers in Arkansas have contracted with NovaSys Health making it one of the largest health plans in Arkansas. They take pride in the relationships that they have cultivated with providers.
$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.
Touchdown Technologies, Inc. designs, manufactures, and supports MEMS probecards. The company offers ACCU-TORQ probe, a torsional contactor; and GIGA-TORQ probecards for DRAM applications. Its products support the production wafer test needs of semiconductor manufacturers. Touchdown Technologies, Inc. was formerly known as Integrated Micromachines, Inc. The company was founded in 2003 and is based in Baldwin Park, California.
Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support. Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.
Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.
Private Equity Round in 2008
POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
AccountNow is a leading provider of prepaid card financial solutions for the 40 million US consumers who do not have established credit, credit cards, or traditional banking relationships. AccountNow’s money saving offers give consumers an alternative to "traditional" checking accounts and access to the financial and payment systems, including Visa prepaid cards, Pay Anyone Bill Payment and FDIC-insured deposits. AccountNow Prepaid Cards are issued by The Bancorp Bank or MetaBank pursuant to a license from Visa U.S.A. Inc. or MasterCard International Incorporated. Cards can be used everywhere Visa debit cards or Debit MasterCard is accepted. MasterCard is a registered trademark of MasterCard International Incorporated. The Bancorp Bank and MetaBank; Members FDIC.
Antenova, Ltd. engages in the design, development, and supply of standard and custom antennas, and radio frequency antenna modules. Its products are used in mobile handsets, adapters, portable devices, laptop computers, and wireless devices. Antenova, Ltd. was incorporated in 1999 and is headquartered in Stow-cum-Quy, the United Kingdom. It has design, and sales and support centers in Taipei, Taiwan; Chicago, Illinois; and Shanghai, China, as well as manufacturing operations in Taiwan and China.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.
Cortina Systems is a leading supplier of intelligent communication solutions through continuous innovations in advanced port processing and connectivity to the Core, Metro, Access, and Enterprise Market Segments. With our state-of-the-art high-speed analogdigital integration, we deliver a wide suite of products that address our customers' performance, density, and flexibility needs enabling faster time-to-market, longer time-in-market, and increased revenue opportunities. Working closely with our customers to understand their system requirements and anticipate their needs, we are creating the foundation ingredients for new generations of services.
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
Private Equity Round in 2006
Xenon Pharmaceuticals is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits or phenotypes. They apply their expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects responsible for such severe phenotypes, they gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, they are developing proprietary product candidates to treat both orphans as well as more prevalent diseases
Touchdown Technologies, Inc. designs, manufactures, and supports MEMS probecards. The company offers ACCU-TORQ probe, a torsional contactor; and GIGA-TORQ probecards for DRAM applications. Its products support the production wafer test needs of semiconductor manufacturers. Touchdown Technologies, Inc. was formerly known as Integrated Micromachines, Inc. The company was founded in 2003 and is based in Baldwin Park, California.
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.
Cortina Systems is a leading supplier of intelligent communication solutions through continuous innovations in advanced port processing and connectivity to the Core, Metro, Access, and Enterprise Market Segments. With our state-of-the-art high-speed analogdigital integration, we deliver a wide suite of products that address our customers' performance, density, and flexibility needs enabling faster time-to-market, longer time-in-market, and increased revenue opportunities. Working closely with our customers to understand their system requirements and anticipate their needs, we are creating the foundation ingredients for new generations of services.
Centrify was merged with Thycotic in 2021 and the combined company rebranded as Delinea, Inc. in February 2022. Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations.
ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.
SkyPilot Networks is a leading provider of carrier-class broadband wireless equipment that enables service providers, municipalities, and public safety agencies to rapidly deploy cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, video surveillance, and other wireless applications. The SkyPilot solution utilizes a patented multi-hop point-to-multipoint architecture that synchronizes high-gain directional antennas to extend reach, mitigate interference, and maximize spectral efficiency. The result is a highly scalable, reliable, and deterministic broadband wireless network that simplifies design, increases deployment flexibility, and dramatically reduces equipment and operating costs. SkyPilot has proven scalability and reliability with units shipped to customers in over 50 countries. SkyPilot is a privately held company based in Santa Clara, California.
Arcot Systems, Inc. offers authentication and digital signing solutions to protect and verify digital identity. The company offers TransFort for Issuers that enables authentication for card holders and merchants; TransFort for Merchants, which enables authentication of cardholders that enroll in 3-D secure; RiskFort that blocks fraud in real-time; WebFort and ArcotID software-only authentication solutions; A-OK On-Demand that provides security for authentication process; and SignFort, which enables organizations to replace ‘print and sign’ methods with streamlined process for signing and approving documents. The company provides solutions for consumer portal protection, FFIEC compliance, identity management, Internet threat protection, SAFE biopharmaceutical compliance, and VPN authentication. It helps financial institutions, pharmaceutical companies, and e-shopping sites to prevent online fraud and identity theft. The company was founded in 1997 and is headquartered in Sunnyvale, California with a technology center in Bangalore, India.
Cast Iron Systems, Inc., a software-as-a-service integration appliance vendor, provides integration appliances for large and midsize companies. The company offers iA3000, an application integration appliance that offers network computing solutions. It also provides preconfigured solutions for enterprise and on-demand applications that enable users to offer connectivity to specific applications, as well as packaged integration processes to integration scenarios; and integration solutions for SAP applications, and Oracle applications and databases. In addition, the company offers consulting, technical support, and education services. Cast Iron Systems, Inc. was formerly known as IronHide Corporation. The company was founded in 2001 and is based in Mountain View, California.
GENBAND is a global supplier of IP gateways, session border controllers and FMC security solutions. These high-performance, high-security gateway solutions are at the center of fixed and mobile networks around the globe, evolving, securing and improving communications networks.
WhereNet Corporation offers wireless solutions for tracking and managing enterprise assets. I WhereNet provides an integrated wireless infrastructure for real-time location, messaging, and telemetry applications, including WhereLAN, a cellular network of locating access points, transmit devices; WhereLAN LOS, a network of tag transmission receivers which perform locations calculations, database functions, and systems management; WhereTag III, a low-powered active radio frequency transmitters associated with an asset; WhereTag IV, an asset tag, which can be configured to match specific location application requirements; WhereCall, a wireless messaging system used for parts replenishment in industrial manufacturing; and WherePort, a magnetic exciter that extends the functionality of WhereTags. The company also offers Visibility Software Server, a set of software development tools for integrating WhereNet, customer, and third-party applications. The company was founded in 1997 and is headquartered in Santa Clara, California. As of January 25, 2007, WhereNet Corporation operates as a subsidiary of Zebra Technologies Corp.
$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.
Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.
SkyPilot Networks is a leading provider of carrier-class broadband wireless equipment that enables service providers, municipalities, and public safety agencies to rapidly deploy cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, video surveillance, and other wireless applications. The SkyPilot solution utilizes a patented multi-hop point-to-multipoint architecture that synchronizes high-gain directional antennas to extend reach, mitigate interference, and maximize spectral efficiency. The result is a highly scalable, reliable, and deterministic broadband wireless network that simplifies design, increases deployment flexibility, and dramatically reduces equipment and operating costs. SkyPilot has proven scalability and reliability with units shipped to customers in over 50 countries. SkyPilot is a privately held company based in Santa Clara, California.
StarVox products are sold and serviced through major solution providers such as Hewlett Packard as a complete, factory-integrated IP telephony solution for service providers. The HP/StarVox Next Generation Telephony Solution combines StarVox software with HP's Open Call Multi Controller application platforms and Cisco Powered Network equipment, making it a carrier-grade, industry-standard solution that will allow a full range of value-added services and upgrades
2Wire is a San Jose, Calif. provider of broadband service products for companies serving consumers.2Wire is dedicated to developing integrated solutions to deliver broadband service and content throughout the home or small office. Built upon the company's core expertise and continued innovation in software and hardware, 2Wire products enable home and small business users to fully leverage the benefits of broadband. In addition, 2Wire solutions offer service providers with a flexible platform to deliver and manage feature-rich Internet, telephony, entertainment, and other enhanced broadband application services
GENBAND is a global supplier of IP gateways, session border controllers and FMC security solutions. These high-performance, high-security gateway solutions are at the center of fixed and mobile networks around the globe, evolving, securing and improving communications networks.
Ishoni Networks develops broadband engines for residential and business customers.
EndPoints Inc. is a fabless semiconductor company that provides controller chips used in mass-market consumer products that capture and display video and still digital images across the internet and other networks. The company’s products control the operation of inexpensive digital video and still cameras that can connect to the Internet. These controller chips process and communicate the images that are captured and digitized by CMOS image sensor chips and are then sent through one of the company’s interfaces (USB, 1394, Ethernet, etc.) to a PC.
Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.